Galapagos N.V. (GLPG) - Net Assets

Latest as of September 2025: €2.88 Billion EUR ≈ $3.36 Billion USD

Based on the latest financial reports, Galapagos N.V. (GLPG) has net assets worth €2.88 Billion EUR (≈ $3.36 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.13 Billion ≈ $4.82 Billion USD) and total liabilities (€1.25 Billion ≈ $1.46 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Galapagos N.V. to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€2.88 Billion
% of Total Assets	69.68%
Annual Growth Rate	32.53%
5-Year Change	8.49%
10-Year Change	693.68%
Growth Volatility	108.65

Galapagos N.V. - Net Assets Trend (2004–2024)

This chart illustrates how Galapagos N.V.'s net assets have evolved over time, based on quarterly financial data. Also explore Galapagos N.V. assets under control for the complete picture of this company's asset base.

Annual Net Assets for Galapagos N.V. (2004–2024)

The table below shows the annual net assets of Galapagos N.V. from 2004 to 2024. For live valuation and market cap data, see GLPG company net worth.

Year	Net Assets	Change
2024-12-31	€2.90 Billion ≈ $3.39 Billion	+3.63%
2023-12-31	€2.80 Billion ≈ $3.27 Billion	+10.67%
2022-12-31	€2.53 Billion ≈ $2.95 Billion	-4.44%
2021-12-31	€2.64 Billion ≈ $3.09 Billion	-1.01%
2020-12-31	€2.67 Billion ≈ $3.12 Billion	-7.14%
2019-12-31	€2.88 Billion ≈ $3.36 Billion	+136.83%
2018-12-31	€1.21 Billion ≈ $1.42 Billion	+19.99%
2017-12-31	€1.01 Billion ≈ $1.18 Billion	+33.38%
2016-12-31	€758.70 Million ≈ $887.00 Million	+107.86%
2015-12-31	€365.00 Million ≈ $426.72 Million	+77.07%
2014-12-31	€206.13 Million ≈ $240.99 Million	+23.33%
2013-12-31	€167.14 Million ≈ $195.40 Million	+41.11%
2012-12-31	€118.45 Million ≈ $138.48 Million	+0.06%
2011-12-31	€118.38 Million ≈ $138.39 Million	-20.29%
2010-12-31	€148.51 Million ≈ $173.62 Million	+36.40%
2009-12-31	€108.88 Million ≈ $127.29 Million	+29.12%
2008-12-31	€84.32 Million ≈ $98.58 Million	-14.50%
2007-12-31	€98.63 Million ≈ $115.30 Million	-9.97%
2006-12-31	€109.54 Million ≈ $128.07 Million	+79.18%
2005-12-31	€61.14 Million ≈ $71.47 Million	+489.72%
2004-12-31	€10.37 Million ≈ $12.12 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Galapagos N.V.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 11311600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	€293.94 Million	10.15%
Other Comprehensive Income	€314.00K	0.01%
Other Components	€2.74 Billion	94.48%
Total Equity	€2.90 Billion	100.00%

Galapagos N.V. Competitors by Market Cap

The table below lists competitors of Galapagos N.V. ranked by their market capitalization.

Company	Market Cap
Zhengzhou GL Tech Co Ltd SHE:300480	$1.85 Billion
NFI Group Inc TO:NFI	$1.85 Billion
Suzhou Victory Precision Manufacture Co Ltd SHE:002426	$1.85 Billion
Calibre Mining Corp TO:CXB	$1.85 Billion
Guangzhou Kingmed Diagnostics Group Co Ltd SHG:603882	$1.85 Billion
Sanquan Food Co Ltd SHE:002216	$1.85 Billion
Hunan Corun New Energy Co Ltd SHG:600478	$1.85 Billion
Hugel Inc KQ:145020	$1.85 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Galapagos N.V.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 2,795,566,000 to 2,896,939,000, a change of 101,373,000 (3.6%).
Net income of 74,082,000 contributed positively to equity growth.
Other comprehensive income increased equity by 7,405,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	€74.08 Million	+2.56%
Other Comprehensive Income	€7.41 Million	+0.26%
Other Changes	€19.89 Million	+0.69%
Total Change	€-	3.63%

Book Value vs Market Value Analysis

This analysis compares Galapagos N.V.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.55x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 13.83x to 0.55x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2004-12-31	€1.75	€24.14	x
2005-12-31	€6.84	€24.14	x
2006-12-31	€8.09	€24.14	x
2007-12-31	€4.77	€24.14	x
2008-12-31	€3.98	€24.14	x
2009-12-31	€5.03	€24.14	x
2010-12-31	€6.12	€24.14	x
2011-12-31	€4.48	€24.14	x
2012-12-31	€4.46	€24.14	x
2013-12-31	€5.81	€24.14	x
2014-12-31	€6.85	€24.14	x
2015-12-31	€10.22	€24.14	x
2016-12-31	€16.60	€24.14	x
2017-12-31	€20.45	€24.14	x
2018-12-31	€23.30	€24.14	x
2019-12-31	€49.91	€24.14	x
2020-12-31	€41.04	€24.14	x
2021-12-31	€40.36	€24.14	x
2022-12-31	€38.45	€24.14	x
2023-12-31	€42.43	€24.14	x
2024-12-31	€43.96	€24.14	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Galapagos N.V. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.56%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 26.88%
• Asset Turnover: 0.07x
• Equity Multiplier: 1.43x
Recent ROE (2.56%) is above the historical average (-7.61%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2004	-34.62%	-46.15%	0.50x	1.51x	€-4.63 Million
2005	-10.70%	-58.19%	0.14x	1.33x	€-12.65 Million
2006	-10.35%	-32.25%	0.21x	1.53x	€-22.29 Million
2007	-22.25%	-33.29%	0.44x	1.51x	€-31.81 Million
2008	-17.30%	-18.95%	0.65x	1.41x	€-23.02 Million
2009	2.76%	3.23%	0.65x	1.32x	€-7.88 Million
2010	2.94%	3.57%	0.63x	1.31x	€-10.48 Million
2011	-27.96%	-34.52%	0.60x	1.36x	€-44.93 Million
2012	-4.83%	-4.20%	0.58x	1.99x	€-17.57 Million
2013	-4.83%	-5.87%	0.48x	1.72x	€-24.79 Million
2014	16.11%	47.88%	0.26x	1.31x	€12.60 Million
2015	-32.44%	-299.29%	0.09x	1.21x	€-154.91 Million
2016	7.12%	41.70%	0.12x	1.43x	€-21.86 Million
2017	-11.43%	-91.04%	0.10x	1.27x	€-216.90 Million
2018	-2.41%	-10.13%	0.20x	1.19x	€-150.68 Million
2019	5.21%	17.73%	0.14x	2.11x	€-137.72 Million
2020	-11.65%	-65.06%	0.08x	2.14x	€-578.04 Million
2021	-4.74%	-25.87%	0.09x	1.96x	€-389.76 Million
2022	-8.63%	-43.14%	0.11x	1.87x	€-470.59 Million
2023	7.57%	88.31%	0.06x	1.56x	€-67.86 Million
2024	2.56%	26.88%	0.07x	1.43x	€-215.61 Million

Industry Comparison

This section compares Galapagos N.V.'s net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $214,163,388
Average return on equity (ROE) among peers: -4.97%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Galapagos N.V. (GLPG)	€2.88 Billion	-34.62%	0.44x	$1.85 Billion
Pharming Group NV (PHARM)	$214.16 Million	-4.97%	0.81x	$927.29 Million

About Galapagos N.V.

AS:GLPG Netherlands Biotechnology

Market Cap

$1.86 Billion

€1.59 Billion EUR

Market Cap Rank

#6546 Global

#47 in Netherlands

Share Price

€24.14

Change (1 day)

+0.67%

52-Week Range

€22.56 - €31.84

All Time High

€249.50